BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
461.79599
NSE Symbol
NATCOPHARM
Divident Yield %
0.72
Market Cap
(Rs In Cr.)
14,937
P/E (TTM)
9.84
EPS (TTM)
84.75
Face Value
(Rs)
2
Date Heading
26-Nov-25 Volumes soar at Carborundum Universal Ltd counter
26-Nov-25 Carborundum Universal Ltd leads gainers in 'A' group
24-Nov-25 Natco Pharma slides after receiving seven USFDA observations for Chenn
21-Nov-25 Natco Pharma concludes USFDA inspection of its API unit in Chennai
20-Nov-25 Volumes jump at Radico Khaitan Ltd counter
14-Nov-25 Board of Natco Pharma recommends interim dividend
14-Nov-25 Natco Pharma fixes record date for interim dividend
14-Nov-25 Natco Pharma consolidated net profit declines 23.46% in the September
10-Nov-25 Natco Pharma to conduct board meeting
07-Nov-25 Natco Pharma Ltd - Natco Pharma Limited - Analysts/Institutional Inves
31-Oct-25 Natco Pharma launches Everolimus tablets 1mg
31-Oct-25 Natco Pharma Ltd - Natco Pharma Limited - Press Release
17-Oct-25 Natco Pharma Ltd - Announcement under Regulation 30 (LODR)-Press Relea
17-Oct-25 Natco Pharma Ltd - Natco Pharma Limited - Press Release
10-Oct-25 Volumes spurt at Tata Communications Ltd counter
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)